Shuki Joshua Hershcovich

Shuki Joshua Hershcovich has an extensive work experience in various roles and industries. In 2013, they founded Sonovia Ltd., a company focused on developing and commercializing antibacterial fabrics. Shuki Joshua successfully negotiated licensing, led financial rounds, and spearheaded collaborations, transforming Sonovia into a thriving company with a turnover of $15 million USD per year.

In 2015, Hershcovich founded Betalin Therapeutics, a game-changing company in diabetes treatment. The company discovered how to generate and implant "micro-organs" that possess the functionalities of a human pancreas, revolutionizing diabetes treatment.

In 1995, they founded Shay Sapir Investment, an investment bank specializing in the Hi-Tech sector. The company focuses on venture-stage middle-market technology and life sciences companies.

Hershcovich also served as an external director for Natural Resources Ltd., representing minority shareholders and monitoring senior management and main shareholders' activities.

Earlier in their career, they founded and served as the general director of Fox Cab, Chestnut Cab, Vicky Cab, and Panndel Cab. Shuki Joshua also founded and served as a director of Galhor Ltd and Amrat Ltd.

Overall, Hershcovich's work experience highlights their entrepreneurial skills, leadership abilities, and success in developing and transforming companies in various industries.

Shuki Joshua Hershcovich attended Bar-Ilan University from 1992 to 1994, where they pursued a degree in Finance, with a specialization in capital markets. Further details about their field of study are not provided.